The BCL11 gene family: Involvement of BCL11A in lymphoid malignancies

Blood

Volumn 98, Issue 12, 2001, Pages 3413-3420

  Satterwhite, Ed ^a,b,c,d   Sonoki, Takashi ^a,b,c,d   Willis, Tony G ^a,b,c,d   Harder, Lana ^a,b,c,d   Nowak, Rachael ^a,b,c,d   Arriola, Emma L ^a,b,c,d   Liu, Hui ^a,b,c,d   Price, Helen P ^a,b,c,d   Gesk, Stefan ^a,b,c,d   Steinemann, Doris ^a,b,c,d   Schlegelberger, Brigitte ^a,b,c,d   Oscier, David G ^a,b,c,d   Siebert, Reiner ^a,b,c,d   Tucker, Philip W ^a,b,c,d   Dyer, Martin J S ^a,b,c,d,e  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; B CELL LEUKEMIA; BCL11 GENE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CHICKEN; CHROMOSOME 14Q; CHROMOSOME 2P; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CPG ISLAND; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOCYTOMA; MOLECULAR CLONING; MULTIGENE FAMILY; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; XENOPUS;

EID: 0035760903     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.12.3413     Document Type: Article

References (35)

1. Willis TG, Dyer MJS. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000;96:808-822.
2. Cigudosa JC, Parsa NZ, Louie DC, et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer. 1999;25:123-133.
3. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96:35-45.
4. Callanan MB, Le Baccon P, Mossuz P, et al. The IgG Fc receptor, FcγRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Proc Natl Acad Sci U S A. 2000;97:309-314.
5. Hatzivassiliou G, Miller I, Takizawa J, et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 2001;14:277-289.
6. Sonoki T, Harder L, Horsman DE, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood. 2001;98:2837-2844.
7. Watson MS, Land VJ, Carroll AJ, et al. t(2;14) (p13;q32): a recurring abnormality in lymphocytic leukemia. A Pediatric Oncology Group study. Cancer Genet Cytogenet. 1992;58:121-124.
8. Geisler CH, Philip P, Christensen BE, HouJensen K, et al. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res. 1997;21:1011-1023.
9. Sonoki T, Matsuzaki H, Satterwhite E, et al. A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14). Acta Haematol. 1999;101:197-201.
10. Yoffe G, Howard-Peebles PN, Smith RG, Tucker PW, Buchanan GR. Childhood chronic lymphocytic leukemia with (2;14) translocation. J Pediatr. 1990;116:114-117.
11. Richardson AL, Humphries CG, Tucker PW. Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia. Oncogene. 1992;7:961-970.
12. Zani VJ, Asou N, Jadayel D, et al. Molecular cloning of complex chromosomal translocation t(8;14;12) (q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene(BCL7A) with homology to caldesmon. Blood. 1996;87:3124-3134.
13. Popescu NC, Dahlberg JE, Ablashi DV, et al. Oncogene expression and immunoglobulin synthesis in a North American Burkitt (NAB-2) lymphoma cell line with a 8;22 chromosome translocation. Oncogene Res. 1990;5:295-303.
14. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II: continuous cell lines. Leuk Lymphoma. 1993;9:1-25.
15. Willis TG, Jadayel DM, Coignet LJ, et al. Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood. 1997;90:2456-2464.
16. Willis TG, Zalcberg IR, Coignet LJ, et al. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood. 1998;91:1873-1881.
17. Satterwhite E. Cloning and analysis of BLTZ, a gene implicated in childhood leukaemia [PhD thesis]. Austin, TX: University of Texas, Austin; 1998.
18. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuhl WM. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci U S A. 1996;93:13931-13936.
19. Schlegelberger B, Metzke S, Harder S, Zühlke-Jenisch R, Zhang Y, Siebert R. Classical and molecular cytogenetics of tumor cells. In: Wegner RD, ed. Diagnostic cytogenetics. Heidelberg, Germany: Springer-Verlag; 1999:151-185.
20. Benjamin IJ, Shelton J, Garry J, Richardson JA. Temporospatial expression of the small HSP/abcrystallin in cardiac and skeletal muscle during development. Dev Dyn. 1997;208:75-84.
21. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev. 1995;5:309-314.
22. Alizadeh AA, Eisen MB, Davis RE, et al. Identification of molecularly and clinically distinct types of diffuse large B cell lymphoma by gene expression profiling. Nature. 2000;403:503-511.
23. Li J, Shen H, Himmel KL, et al. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet. 1999;23:348-353.
24. Nakamura T, Yamazaki Y, Saiki Y, et al. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell protooncogene product. Mol Cell Biol. 2000;20:3178-3186.
25. (2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J Biol Chem. 2000;275:10315-10322.
26. Houldsworth J, Mathew S, Rao PH, et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 1996;87:25-29.
27. Joos S, Otano-Joos MI, Ziegler S, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood. 1996;87:1571-1578.
28. Barth TF, Dohner H, Werner CA, et al. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood. 1998;91:4321-4330.
29. Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 1998;92:234-240.
30. Joos S, Kupper M, Ohl S, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 2000;60:549-552.
31. Goff LK, Neat MJ, Crawley CR, et al. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br J Haematol. 2000;111:618-625.
32. Saiki Y, Yamazaki Y, Yoshida M, Katoh O, Nakamura T. Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoletic progenitors and down-regulated during myeloid differentiation of HL60 cells. Genomics. 2000;70:387-391.
33. Staudt LM. The molecular and cellular origins of Hodgkin's disease. J Exp Med. 2000;191:207-212.
34. Carbone A, Gloghini A, Gaidano G, et al. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood. 1998;92:2220-2228.
35. Takizawa J, Suzuki R, Kuroda H, et al. Expression of the TCL 1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn J Cancer Res. 1998;89:712-718.